BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Passiatore M, Cilli V, Cannella A, Caruso L, Sassara GM, Taccardo G, De Vitis R. Long-term assessment of collagenase treatment for Dupuytren’s contracture: A 10-year follow-up study. World J Orthop 2024; 15(4): 355-362 [PMID: 38680672 DOI: 10.5312/wjo.v15.i4.355]
URL: https://www.wjgnet.com/2218-5836/full/v15/i4/355.htm
Number Citing Articles
1
Michael Nocek, Dorothy Wakefield, Mark A. Vitale. Likelihood of Dupuytren Contracture Recurrence After Limited Fasciectomy, Needle Aponeurotomy or Collagenase Clostridium histolyticum: Systematic Review of Prospective Data With 2- to 7-Year Follow-upJournal of Hand Surgery Global Online 2026; 8(3): 100979 doi: 10.1016/j.jhsg.2026.100979
2
Nikolaus Wachtel, Francesca Romana Dingler, Constanze Kuhlmann, Sinan Mert, Elisabeth Maria Haas-Lützenberger, Verena Alt, Nicholas Moellhoff, Riccardo Giunta, Wolfram Demmer. Therapy for Dupuytren’s Disease (II): Collagenase Therapy vs. Limited Fasciectomy—A Long-Term Comparative StudyLife 2025; 15(1): 76 doi: 10.3390/life15010076
3
Wibke Müller-Seubert, Aijia Cai, Raymund E. Horch. Application of Near Infrared Spectroscopy to Enhance Safety and Individualize Distraction of Severely Contracted Joints in Far-Advanced Dupuytren’s DiseaseJournal of Clinical Medicine 2024; 13(14): 4025 doi: 10.3390/jcm13144025
4
Camillo Fulchignoni, Silvia Pietramala, Marco Barbaliscia, Marco Passiatore, Ludovico Caruso, Adriano Cannella, Gianfranco Merendi, Lorenzo Rocchi, Giuseppe Taccardo, Rocco de Vitis. Ten-Year Follow-Up: Collagenase Injection Versus Open Surgery for Dupuytren’s DiseaseSurgeries 2026; 7(1): 34 doi: 10.3390/surgeries7010034
5
Evan H. Richman, Dylan Rakowski, Alexander Lauder. TEMPORARY REMOVAL: The Impact of Emerging Therapies and Declining Physician Reimbursement on Dupuytren Disease Treatment: A 21-Year ReviewThe Journal of Hand Surgery 2026; 51(3): 312 doi: 10.1016/j.jhsa.2025.03.013